Applied Therapeutics, Inc. (APLT) Financials
Stock symbol APLT is outdated, potentially delisted? Maybe it is available on other exchange?
APLT Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2025 | 34.4 million | 34.9 million |
| June 30, 2025 | 37.3 million | 19.9 million |
| March 31, 2025 | 56.9 million | 20.2 million |
| Dec. 31, 2024 | 86.7 million | 29.7 million |
APLT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2025 | -18.4 million | 1.1 million |
| June 30, 2025 | -20.3 million | 2.1 million |
| March 31, 2025 | -28.6 million | 1.5 million |
| Dec. 31, 2024 | -19.5 million | 7.1 million |
APLT Net Income
No data available :(
APLT Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2025 | 11.9 million | 2.0 million | 2.5 million |
| June 30, 2025 | 30.4 million | 2.2 million | 2.6 million |
| March 31, 2025 | 50.8 million | 2.3 million | 2.7 million |
| Dec. 31, 2024 | 79.4 million | 2.4 million | 2.8 million |
APLT Shares Outstanding
APLT Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2025 | - | 9.6 million | 9.4 million | - |
| June 30, 2025 | - | 9.9 million | 13.2 million | 206000 |
| March 31, 2025 | - | 7.8 million | 17.7 million | 206000 |
| Dec. 31, 2024 | - | 11.7 million | 21.3 million | 163000 |
APLT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2025 | 1.0 million | - |
| June 30, 2025 | - | 9.9 million |
| March 31, 2025 | -1000 | 7.8 million |
| Dec. 31, 2024 | - | 11.7 million |
APLT Revenue by Segment
Graph available only for paid members. Upgrade to see it.
APLT
Price: $0.10
52 week price:
Earnings Per Share: -0.10 USD
P/E Ratio: -1.03
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 546852
Market Capitalization: 14.9 million